Neovision Capital
Neovision Capital, established in 2015 and headquartered in Shanghai, China, is an investment firm focused on venture capital investments in early and growth-stage companies. The firm's founders bring a wealth of experience from prominent financial institutions, including Costone Capital and J.P. Morgan. Neovision Capital targets sectors such as healthcare, information technology, telecommunications, media, and technology. The company leverages its team's extensive operational experience in China, along with international resources, to provide strategic support to its portfolio companies. This includes expertise in areas such as branding, marketing, channel development, overseas expansion, human resources, and finance. Neovision Capital also maintains a presence in Nanjing, enhancing its ability to identify and nurture promising ventures within its preferred industries.
Xgene Pharmaceutical
Series C in 2021
Xgene Pharmaceutical Inc. is a late-clinical stage pharmaceutical company established in 2015, based in the Cayman Islands. It focuses on developing small-molecule drugs aimed at treating chronic pain, infectious diseases, and tumors. Utilizing proprietary linker technology, Xgene creates novel, multimodal conjugated molecules that enhance the efficacy and tolerability of pain medications. The company's current programs are dedicated to addressing unmet needs in neurological disorders, making significant strides in the development of innovative treatments for these conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.